NeuroSense Therapeutics Ltd. (NRSN) Insider Trading

Name: NeuroSense Therapeutics Ltd. (NRSN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 17, 2026): Alon Ben-Noon (Chief Executive Officer): Purchase of 250,000 shares, $200.0K.

Get alerted when insiders trade NRSN

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta